Correction of the Delta phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine.

Source:http://linkedlifedata.com/resource/pubmed/id/20200141

Download in:

View as

General Info

PMID
20200141